Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

ePlus Lowers FY2025 Sales Guidance from $2.29B-2.36B to $2.07B-2.11B vs $2.20B Est

Author: Benzinga Newsdesk | February 05, 2025 04:21pm
ePlus (NASDAQ:PLUS) lowers FY2025 sales outlook from $2.29 billion-2.36 billion to $2.07 billion-2.11 billion vs $2.20 billion estimate.

Posted In: PLUS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist